These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 26427987)

  • 41. Bleb vascularity following post-trabeculectomy subconjunctival bevacizumab: a pilot study.
    Chua BE; Nguyen DQ; Qin Q; Ruddle JB; Wells AP; Niyadurupola N; Gupta V; Wong TT; Coote MA; Crowston JG
    Clin Exp Ophthalmol; 2012 Nov; 40(8):773-9. PubMed ID: 22429268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potential Effect of Tumor Necrosis Factor Inhibitors on Trabeculectomy With Mitomycin C for Patients With Juvenile Idiopathic Arthritis-Related Uveitic Glaucoma: A Retrospective Analysis.
    Leinonen S; Kotaniemi K; Kivelä T; Majander A
    JAMA Ophthalmol; 2015 Nov; 133(11):1323-8. PubMed ID: 26402863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study.
    José P; Teixeira FJ; Barão R; Sousa DC; Marques RE; Barata ADO; Marques-Neves C; Alves M; Papoila AL; Stalmans I; Silva JP; Abegão Pinto L
    Br J Ophthalmol; 2022 Oct; 106(10):1399-1405. PubMed ID: 33931389
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparison study on the efficacy and safety of bevacizumab versus mitomycin C as adjuvants in trabeculectomy].
    Martín Giral E; Rivera Zori M; Perucho Martínez S; Toledano Fernández N
    Arch Soc Esp Oftalmol; 2015 Feb; 90(2):63-8. PubMed ID: 25443461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mitomycin C-augumented trabeculectomy with postoperative wound modulation in pediatric glaucoma.
    Freedman SF; McCormick K; Cox TA
    J AAPOS; 1999 Apr; 3(2):117-24. PubMed ID: 10221807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mitomycin C-augmented trabeculectomy: subtenon injection versus soaked sponges: a randomised clinical trial.
    Pakravan M; Esfandiari H; Yazdani S; Douzandeh A; Amouhashemi N; Yaseri M; Pakravan P
    Br J Ophthalmol; 2017 Sep; 101(9):1275-1280. PubMed ID: 28100482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive value of early IOP in mitomycin-C augmented trabeculectomy.
    Alwitry A; Moodie J; Rotchford A; Abedin A; Patel V; King AJ
    J Glaucoma; 2007; 16(7):616-21. PubMed ID: 18091180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Short-term Effect of Subtenon Sponge Application Versus Subtenon Irrigation of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device: A Randomized Trial.
    Quist MS; Brown N; Bicket AK; Herndon LW
    J Glaucoma; 2018 Feb; 27(2):148-156. PubMed ID: 29189540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trabeculectomy with combined use of subconjunctival collagen implant and low-dose mitomycin C.
    Dada T; Kusumesh R; Bali SJ; Sharma S; Sobti A; Arora V; Panda A
    J Glaucoma; 2013; 22(8):659-62. PubMed ID: 23059478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-penetrating glaucoma surgery augmented with mitomycin C or 5-fluorouracil in eyes at high risk of failure of filtration surgery: long-term results.
    Choudhary A; Wishart PK
    Clin Exp Ophthalmol; 2007; 35(4):340-7. PubMed ID: 17539786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma.
    Marey HM; Mandour SS; Ellakwa AF
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):330-4. PubMed ID: 23113645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study.
    Grewal DS; Jain R; Kumar H; Grewal SP
    Ophthalmology; 2008 Dec; 115(12):2141-2145.e2. PubMed ID: 18692246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of needle revision with subconjunctival bevacizumab and 5-fluorouracil injection of failed trabeculectomy blebs.
    Simsek T; Cankaya AB; Elgin U
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):542-6. PubMed ID: 22731246
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma.
    Mandal AK; Prasad K; Naduvilath TJ
    Ophthalmic Surg Lasers; 1999 Jun; 30(6):473-80. PubMed ID: 10392736
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing safety and success after using bevacizumab, 5-fluorouracil or placebo in primary trabeculectomy. A prospective randomized placebo controlled 1-year follow-up study.
    Kandarakis S; Kontaxakis A; Doumazos L; Petrou P; Droutsas K; Papaconstantinou D; Georgalas I
    Cutan Ocul Toxicol; 2022 Mar; 41(1):25-32. PubMed ID: 34749555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravitreal bevacizumab improves trabeculectomy survival at 12 months: the bevacizumab in trabeculectomy study-a randomised clinical trial.
    Landers JA; Mullany S; Craig JE
    Br J Ophthalmol; 2024 May; 108(5):679-686. PubMed ID: 37541768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment Outcomes of Mitomycin C-Augmented Trabeculectomy, Sub-Tenon Injection versus Soaked Sponges, after 3 Years of Follow-up: A Randomized Clinical Trial.
    Esfandiari H; Pakravan M; Yazdani S; Doozandeh A; Yaseri M; Conner IP
    Ophthalmol Glaucoma; 2018; 1(1):66-74. PubMed ID: 32672635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intermediate and Long-term Outcomes of Mitomycin C-enhanced Trabeculectomy as a First Glaucoma Procedure in Uveitic Glaucoma.
    Almobarak FA; Alharbi AH; Morales J; Aljadaan I
    J Glaucoma; 2017 May; 26(5):478-485. PubMed ID: 28234684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary trabeculectomy with mitomycin C: safety and efficacy at 2 years.
    Lusthaus JA; Kubay O; Karim R; Wechsler D; Booth F
    Clin Exp Ophthalmol; 2010 Dec; 38(9):831-8. PubMed ID: 20572827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trabeculectomy With Mitomycin-C Versus Trabeculectomy With Amniotic Membrane Transplant: A Medium-term Randomized, Controlled Trial.
    Khairy HA; Elsawy MF
    J Glaucoma; 2015 Sep; 24(7):556-9. PubMed ID: 24844538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.